Scientific article
OA Policy
French

Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives

Published in

Revue médicale suisse, vol. 4, no. 171, p. 1994-1996,1998-9

Publication date

2008

Abstract

Despite a better overall tolerance as compared to classical antipsychotics, atypical antipsychotics are not devoid of side-effects, notably metabolic factors (weight gain, alteration of lipid and glucose profile). These side-effects are very troubling concerning long term morbidity and mortality and may also influence compliance towards drugs. The department of psychiatry of the Hospital University Centre has established a guideline on the clinical monitoring of patients receiving atypical antipsychotics, based on recently published consensus, which will be presented here. In addition, recent studies show that weight gain and metabolic alterations induced by this type of medication may be influenced by the genetic background of the patients. Such studies should allow, in the near future, to adapt the treatment for each patient.

Keywords

  • Antidepressive Agents, Second-Generation/adverse effects
  • Glucose Intolerance/chemically induced
  • Humans
  • Leptin/genetics
  • Metabolic Syndrome X/chemically induced/genetics
  • Pharmacogenetics
  • Receptors, Leptin/genetics
  • Weight Gain/drug effects

Citation (ISO format)

CHOONG, Eva et al. Follow-up of the metabolic syndrome induced by atypical antipsychotics: recommendations and pharmacogenetics perspectives. In: Revue médicale suisse, 2008, vol. 4, n° 171, p. 1994–1996,1998–9.

Main files (1)

Article (Accepted version)

Identifiers

Journal ISSN

1660-9379
793views
552downloads

Technical informations

Creation

08/09/2011 20:59:00

First validation

08/09/2011 20:59:00

Update

14/03/2023 16:54:11

Status update

14/03/2023 16:54:11

Last indexation

29/10/2024 18:23:00
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated